Kissei Pharmaceutical Co., Ltd. (OTCMKTS:KSPHF – Get Free Report) was the recipient of a significant decrease in short interest during the month of July. As of July 15th, there was short interest totaling 25,239 shares, a decrease of 50.1% from the June 30th total of 50,577 shares. Based on an average daily volume of 0 shares, the days-to-cover ratio is presently ∞ days.
Kissei Pharmaceutical Price Performance
OTCMKTS KSPHF remained flat at $25.77 during trading hours on Tuesday. The firm’s 50 day moving average price is $25.77 and its two-hundred day moving average price is $26.17. Kissei Pharmaceutical has a 52-week low of $23.23 and a 52-week high of $31.90.
About Kissei Pharmaceutical
Kissei Pharmaceutical Co, Ltd. is a Japan-based pharmaceutical company that specializes in the research, development and manufacture of prescription drugs across a range of therapeutic areas. Founded in 1946 and incorporated in 1950, Kissei has built a reputation for its work in urology, nephrology, endocrinology, respiratory medicine and oncology. Through its dedicated in-house research centers, the company advances novel small molecules and biologic candidates from early discovery through clinical development.
The company’s product portfolio includes treatments for benign prostatic hyperplasia, chronic kidney disease, type 2 diabetes and various forms of cancer.
Featured Articles
- Five stocks we like better than Kissei Pharmaceutical
- Nano Nuclear’s Air Force Contract Puts Its Short-Squeeze Setup in Focus
- Amkor Sells Off After Earnings—Why Weak Guidance Isn’t the Real Story
- 5 Space Stocks Face a Brutal Correction: Which Ones Are Still Buys?
- Whirlpool’s Report May Show How Frozen the Housing Market Really Is
Receive News & Ratings for Kissei Pharmaceutical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kissei Pharmaceutical and related companies with MarketBeat.com's FREE daily email newsletter.
